Literature DB >> 2401263

Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6C3F1 mice following 65 weeks of exposure.

R L Melnick1, J E Huff, J H Roycroft, B J Chou, R A Miller.   

Abstract

1,3-Butadiene, a large-production volume chemical used mainly in the manufacture of synthetic rubber, was found to induce multiple-organ carcinogenicity in male and female B6C3F1 mice at exposure concentrations (625 and 1250 ppm) equivalent to and below the OSHA standard of 1000 ppm. Since this study was terminated after 60 weeks of exposure because of reduced survival due to fatal tumors, and because dose-response relationships for 1,3-butadiene-induced neoplastic and nonneoplastic lesions were not clearly established, a second long-term inhalation study of 1,3-butadiene in B6C3F1 mice was conducted at lower exposure concentrations, ranging from 6.25 to 625 ppm. Both the histopathological findings from animals dying through week 65 and the results of evaluations of animals exposed for 40 and 65 weeks are presented in this report. Exposure to 1,3-butadiene caused a regenerative anemia at concentrations of 62.5 ppm and higher. Testicular atrophy was induced at 625 ppm, and ovarian atrophy was observed at 20 ppm and higher. During the first 50 weeks of the study, lymphocytic lymphoma was the major cause of death of mice exposed to 625 ppm 1,3-butadiene. Neoplasms of the heart, forestomach, lung, Harderian gland, mammary gland, ovary, and liver were frequently observed in 1,3-butadiene-exposed mice that died between week 40 and week 65 of the study. Studies in which exposure to 1,3-butadiene was stopped after limited periods were also included to assess the relationship between exposure levels and duration of exposures on the outcome of 1,3-butadiene-induced carcinogenicity. In these studies, lymphocytic lymphomas were induced in male mice exposed to 625 ppm 1,3-butadiene for only 13 weeks. The incidence of lymphocytic lymphoma in male mice exposed to 625 ppm 1,3-butadiene for 26 weeks was two times that in mice exposed to 625 ppm for 13 weeks. However, when the exposure concentration was reduced by half to 312 ppm and the exposure duration extended to 52 weeks, the incidence of lymphocytic lymphoma was reduced by 90%. Thus, the multiple of the exposure concentration times the exposure duration did not predict the incidence of lymphocytic lymphoma in mice. The early mortalities resulting from lymphocytic lymphomas in male mice exposed to 625 ppm 1,3-butadiene limited the expression of tumors at other sites. A clearer dose-response for 1,3-butadiene-induced neoplasia should be apparent from experiments in mice exposed to lower concentrations of this chemical for 2 years.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2401263      PMCID: PMC1567751          DOI: 10.1289/ehp.908627

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  24 in total

1.  Mutagenicity of butadiene and butadiene monoxide.

Authors:  C de Meester; F Poncelet; M Roberfroid; M Mercier
Journal:  Biochem Biophys Res Commun       Date:  1978-01-30       Impact factor: 3.575

2.  Concentrations of hydrocarbons in tissues as a measure of toxicity.

Authors:  B B Shugaev
Journal:  Arch Environ Health       Date:  1969-06

3.  Cardiac tumors of mice.

Authors:  C Hoch-Ligeti; H L Stewart
Journal:  J Natl Cancer Inst       Date:  1984-06       Impact factor: 13.506

4.  Effect of short-term inhalation exposure to 1,3-butadiene on murine immune functions.

Authors:  L M Thurmond; L D Lauer; R V House; W S Stillman; R D Irons; W H Steinhagen; J H Dean
Journal:  Toxicol Appl Pharmacol       Date:  1986-11       Impact factor: 4.219

5.  Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats.

Authors:  P E Owen; J R Glaister; I F Gaunt; D H Pullinger
Journal:  Am Ind Hyg Assoc J       Date:  1987-05

6.  Hepatic microsomal metabolism of 1,3-butadiene.

Authors:  E Malvoisin; M Roberfroid
Journal:  Xenobiotica       Date:  1982-02       Impact factor: 1.908

7.  Macrocytic-megaloblastic anemia in male B6C3F1 mice following chronic exposure to 1,3-butadiene.

Authors:  R D Irons; C N Smith; W S Stillman; R S Shah; W H Steinhagen; L J Leiderman
Journal:  Toxicol Appl Pharmacol       Date:  1986-03-30       Impact factor: 4.219

8.  Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics.

Authors:  R Kreiling; R J Laib; J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

9.  Species differences in the disposition of inhaled butadiene.

Authors:  J A Bond; A R Dahl; R F Henderson; J S Dutcher; J L Mauderly; L S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  1986-07       Impact factor: 4.219

10.  Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure.

Authors:  J E Huff; R L Melnick; H A Solleveld; J K Haseman; M Powers; R A Miller
Journal:  Science       Date:  1985-02-01       Impact factor: 47.728

View more
  17 in total

1.  Structure of the 1,4-bis(2'-deoxyadenosin-N6-yl)-2R,3R-butanediol cross-link arising from alkylation of the human N-ras codon 61 by butadiene diepoxide.

Authors:  W Keither Merritt; Lubomir V Nechev; Tandace A Scholdberg; Stephen M Dean; Sarah E Kiehna; Johanna C Chang; Thomas M Harris; Constance M Harris; R Stephen Lloyd; Michael P Stone
Journal:  Biochemistry       Date:  2005-08-02       Impact factor: 3.162

2.  Structure of the 1,4-Bis(2'-deoxyadenosin-N(6)-yl)-2S,3S-butanediol intrastrand DNA cross-link arising from butadiene diepoxide in the human N-ras codon 61 sequence.

Authors:  Wen Xu; W Keither Merritt; Lubomir V Nechev; Thomas M Harris; Constance M Harris; R Stephen Lloyd; Michael P Stone
Journal:  Chem Res Toxicol       Date:  2007-01-27       Impact factor: 3.739

3.  Dual roles of glycosyl torsion angle conformation and stereochemical configuration in butadiene oxide-derived N1 beta-hydroxyalkyl deoxyinosine adducts: a structural perspective.

Authors:  W Keither Merritt; Agnieszka Kowalczyk; Tandace A Scholdberg; Stephen M Dean; Thomas M Harris; Constance M Harris; R Stephen Lloyd; Michael P Stone
Journal:  Chem Res Toxicol       Date:  2005-07       Impact factor: 3.739

4.  Quantitative analysis of N-terminal valine peptide adducts specific for 1,2-epoxy-3-butene.

Authors:  Nadia I Georgieva; Gunnar Boysen; Patricia B Upton; Karupiah Jayaraj; Avram Gold; James A Swenberg
Journal:  Chem Biol Interact       Date:  2006-06-03       Impact factor: 5.192

5.  Formation of mono- and bis-Michael adducts by the reaction of nucleophilic amino acids with hydroxymethylvinyl ketone, a reactive metabolite of 1,3-butadiene.

Authors:  Nella Barshteyn; Adnan A Elfarra
Journal:  Chem Res Toxicol       Date:  2009-05       Impact factor: 3.739

6.  Mass spectral analyses of hydroxymethylvinyl ketone-hemoglobin adducts formed after in vivo exposure of Sprague-Dawley rats to 3-butene-1,2-diol.

Authors:  Nella Barshteyn; Adnan A Elfarra
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

7.  Inhalation toxicology of isoprene in F344 rats and B6C3F1 mice following two-week exposures.

Authors:  R L Melnick; J H Roycroft; B J Chou; H A Ragan; R A Miller
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

Review 8.  Critical assessment of epidemiologic studies on the human carcinogenicity of 1,3-butadiene.

Authors:  P J Landrigan
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

9.  Ovarian cancer mouse models: a summary of current models and their limitations.

Authors:  Miranda Y Fong; Sham S Kakar
Journal:  J Ovarian Res       Date:  2009-09-28       Impact factor: 4.234

Review 10.  Chemicals and cancer in humans: first evidence in experimental animals.

Authors:  J Huff
Journal:  Environ Health Perspect       Date:  1993-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.